XL-protein and Wacker demonstrate high-yield production of PASylated biopharmaceuticals using ESETEC®
Munich / Jena, June 11, 2012 – Wacker Biotech and XL-protein…
XL-protein announces in vitro and in vivo data for its PASylated hGH
FREISING, GERMANY, September 23, 2011 – XL-protein GmbH, a…
European patent granted for XL-protein’s PASylation® technology
FREISING, GERMANY, MARCH 17th, 2011 – XL-protein GmbH, a German…